| SWEDISH ORPHAN BIOVITRUM |
| Schweden |
| Gesundheit |
| SE0000872095 / A0LA5K |
| B6E (Frankfurt) |
| FRA:B6E, ETR:B6E, B6E:GR |
| - |
| https://www.sobi.com/ |
|
Swedish Orphan Biovitrum AB is an international biopharmaceutical company headquartered in Stockholm, Sweden, specializing in treatments for rare diseases within haematology, immunology, and specialty care. It focuses on researching, developing, manu..
>Volltext.. |
| 14274.18 Mio. EUR |
| 15918.92 Mio. EUR |
| 2667.09 Mio. EUR |
| 1707.59 Mio. EUR |
| 84.83 Mio. EUR |
| 0.24 EUR |
| 1755.67 Mio. EUR |
| 86.58 Mio. EUR |
| 681.32 Mio. EUR |
| 0.04 |
| 9.59% |
| -76.91% |
| - |
| - |
| - |
| - |
| SWEDISH ORPHAN |
| 16.07.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|